Potent and selective inhibition of CDK7 by novel covalent inhibitors

被引：0
|
作者：
Satyam, L. [1 ]
Poddutoori, R. [1 ]
Mukherjee, S. [1 ]
Marappan, S. [1 ]
Gopinath, S. [1 ]
Pothuganti, M. [1 ]
Nayak, S. [1 ]
Kaza, L. [1 ]
Nandish, C. [1 ]
Amith, A. [1 ]
Ravindra, M. [1 ]
Nagaraju, A. [1 ]
Antony, T. [1 ]
Pandit, C. [1 ]
Chelur, S. [1 ]
Daginakatte, G. [1 ]
Samajdar, S. [1 ]
Ramachandra, M. [1 ]
机构：
[1] Aurigene Discovery Technol Ltd, Preclin Biol, Bangalore, Karnataka, India
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 69卷
关键词：
D O I：
10.1016/S0959-8049(16)32978-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
386
引用
收藏
页码：S127 / S127
页数：1
相关论文
共 50 条
  • [1] Potent and selective inhibition of CDK7 by novel covalent inhibitors
    Satyam, Leena Khare
    Poddutoori, Ramulu
    Mukherjee, Subhendu
    Marappan, Sivapriya
    Gopinath, Sreevalsam
    Ramachandra, Raghuveer
    Pothuganti, Manoj Kumar
    Nayak, Shilpa S.
    Nandish, C.
    Naik, Chandranath
    Ravindra, M., V
    Dabbeeru, Madhu B.
    Nagaraju, A.
    Mahankali, B.
    Antony, Thomas
    Pandit, Chetan
    Chelur, Shekar
    Daginakatte, Girish
    Sannajdar, Susanta
    Ramachandra, Murali
    CANCER RESEARCH, 2016, 76
  • [2] Identification of a novel highly selective and orally bioavailable preclinical candidate for CDK7 covalent inhibition
    Poddutoori, Ramulu
    Satyam, Leena Khare
    Mukherjee, Subhendu
    Marappan, Sivapriya
    Gopinath, Sreevalsam
    Charamanna, K. B.
    Kaza, Lakshmi Narayana
    Pothuganti, Manoj Kumar
    Rajagopalan, Sujatha
    Sivakumar, Sasirekha
    Bharath, E. N.
    Aravind, A. B.
    Amith, A.
    Ravindra, M., V
    Tgore, Suraj
    Antony, Thomas
    Pandit, Chetan
    Chelur, Shekar
    Daginakatte, Girish
    Ramachandra, Murali
    Samajdar, Susanta
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [3] Potent selective and orally bioavailable inhibition of CDK12 by novel covalent inhibitors
    Poddutoori, Ramulu
    Rajagopalan, Sujatha
    Mukherjee, Subhendu
    Marappan, Sivapriya
    Samiulla, D. S.
    Kasturi, Venkateswarlu
    Sivakumar, Sasirekha
    Nayak, Shilpa
    Ravindra, M., V
    Tgore, Suraj
    Dhudashiya, Amit
    Charamanna, K. B.
    Antony, Thomas
    Mahaboobi, M.
    Giri, Sanjeev
    Daginakatte, Girish C.
    Chelur, Shekar
    Ramachandra, Murali
    Pandit, Chetan
    Samajdar, Susanta
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [4] Potent anti-tumor activity of AUR102, a selective covalent inhibitor of CDK7
    Satyam, L. K.
    Poddutoori, R.
    Thiyagarajan, S.
    Mukherjee, S.
    Kaza, L. N.
    Charamanna, K.
    Marappan, S.
    Samiulla, D.
    Tiwari, N. K.
    Devaraja, T.
    Aravind, A.
    Dhudashiya, A. A.
    Booher, R.
    Daginakatte, G.
    Antony, T.
    Chelur, S.
    Nellore, K.
    Giri, S.
    Ramachandra, M.
    Samajdar, S.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S47 - S47
  • [5] Precision Retargeting: A Selective Covalent Inhibitor Illuminates CDK7 Biology
    Jones, Lyn H.
    CELL CHEMICAL BIOLOGY, 2019, 26 (06): : 779 - 780
  • [6] CDK7 INHIBITION IN AT/RT
    Morin, Andrew
    Veo, Bethany
    Fosmire, Susan
    Crespo, Michele
    Zahedi, Shadi
    Vibhakar, Rajeev
    Levy, Jean M. Mulcahy
    NEURO-ONCOLOGY, 2020, 22 : 279 - 280
  • [7] Identification of a novel preclinical candidate for CDK7 inhibition
    Satyam, Leena K.
    Poddutoori, Ramulu
    Mukherjee, Subhendu
    Marappan, Sivapriya
    Gopinath, Sreevalsam
    Basavaraju, Aravind
    Kaza, Lakshmi Narayana
    Pothuganti, Manoj Kumar
    Nayak, Shilpa
    Nandish, C.
    Ravindra, Amith A.
    Babu, Dabbeeru Madhu
    Nagaraju, A.
    Tgore, Suraj
    Antony, Thomas
    Pandit, Chetan
    Ramachandra, Murali
    Chelur, Shekar
    Daginakatte, Girish
    Samajdar, Susanta
    CANCER RESEARCH, 2017, 77
  • [8] CDK7 INHIBITION IN AT/RT
    Morin, Andrew
    Wodetzki, Darya
    Veo, Bethany
    Pierce, Angela
    Zahedi, Shadi
    Crespo, Michele
    Venkataraman, Sujatha
    Vibhakar, Rajeev
    Mulcahy-Levy, Jean
    NEURO-ONCOLOGY, 2022, 24 : 8 - 8
  • [9] Selective inhibition of CDK7 ameliorates experimental arthritis in mice
    Yong Xia
    Li-Ying Lin
    Mei-Ling Liu
    Zheng Wang
    Hong-Hai Hong
    Xu-Guang Guo
    Guo-Quan Gao
    Clinical and Experimental Medicine, 2015, 15 : 269 - 275
  • [10] Selective inhibition of CDK7 ameliorates experimental arthritis in mice
    Xia, Yong
    Lin, Li-Ying
    Liu, Mei-Ling
    Wang, Zheng
    Hong, Hong-Hai
    Guo, Xu-Guang
    Gao, Guo-Quan
    CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 15 (03) : 269 - 275
12345